AHFS January 2023 Update

This update contains 12 new monographs, 15 revised monographs and 1 new MedWatch alert.

New monographs: Chloroprocaine (EENT); Eflapegrastim; Emtricitabine and Tenofovir Alafenamide; Emtricitabine and Tenofovir Disoproxil Fumarate; Mirvetuximab Soravtansine-gynx; Mitapivat; Sodium Phenylbutyrate and Taurursodiol; Sutimlimab; Tapinarof; Tremelimumab; Vonoprazan and Amoxicillin; Vonoprazan, Clarithromycin, and Amoxicillin.

Revised monographs: Abrocitinib (Topical); Asciminib; COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Novavax); COVID-19 Vaccine (Pfizer-BioNTech); Darolutamide; Empagliflozin; Fostemsavir; Imipenem, Cilastatin Sodium, and Relebactam; Ivacaftor; Lasmiditan; Margetuximab; Naltrexone and bupropion; Peginterferon Beta-1a; Ropeginterferon Alfa-2b.

New MedWatch alert on the following monograph: Belantamab Mafodotin-blmf.